rTMS for Military TBI-related Depression
Key facts
- Who runs it
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Where
- Fort Belvoir, Fort Bliss, and Palo Alto, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 198 people, planned
- Started
- 16 Dec 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Sham rTMS
- Record updated
- 29 April 2026
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 26 criteriaShow less
Who can take part
- Age 18-55 at the time of consent. Older individuals will not be enrolled in this initial trial for reasons of safety and expected reduced efficacy
- Current or former US military service member eligible for care at a Military Treatment Facility (MTF) or Veterans Administration Medical Center (VAMC.)
- Able to provide written, informed consent in English
- Self-reported or medically diagnosed history of concussion (synonymous with "mild TBI.") >6 months, but <26 years prior to consent, defined based on the DoD/VA definition:; Positive Loss of Consciousness of <30 minutes as confirmed by the TBI Screener and/or medical records and/or; Positive Alteration of Consciousness of <24 hours as confirmed by the TBI Screener and/or medical records and/or; Positive Post-traumatic Amnesia of 0 to 1 day as confirmed by the TBI Screener and/or medical records; Note: Neuroimaging data or documentation from medical records is not required
- Baseline MADRS >13 at the time of screening indicating at least mild-moderate depressive symptoms
- Maintained a steady psychotropic medication regimen for six weeks and a steady behavioral therapy regimen for twelve weeks prior to enrollment in the study
- Female participants with child-bearing potential must agree to use an effective method of birth control during the course of the study
- Under the care of a primary care and/or behavioral health provider
Who cannot take part
- Elevated risk of seizures at the time of rTMS including any of the following:; History of unprovoked seizures; History of seizure within 24 hours of sustaining a concussion(s) or other head injury regardless of whether it was determined to have been related to concussion; Family history of two or more unprovoked seizures in a first degree relative (parent, sibling, or child); History of Moderate, Severe, or Penetrating TBI based on TBI Screener and/or medical records; Intracranial lesion (such as intracranial tumor or intraparenchymal hemorrhage) that, in the opinion of the investigators, would increase seizure risk; Currently taking medication or other substances (such as tricyclic antidepressants or neuroleptics) that, in the opinion of the investigator, lowers the seizure threshold
- Severe claustrophobia interfering with medication/sedation-free 3T closed-bore MRI
- Any implant, prosthesis or other permanent alteration of the body (such as implanted neurostimulators and medication pumps) that, in the opinion of the investigator, would be unsafe with MRI or TMS or that would produce an artifact that would compromise the integrity of data
- Concomitant or lifetime history of receiving open-label TMS, due to issues preserving blinding
- Concomitant or recent history (within 12 weeks prior to enrollment) of receiving other neurostimulatory treatment, including but not limited to transcranial direct current (tDCS), transcranial alternating current (tACS), alpha stim, or electroconvulsive therapy
- Suicide attempt within six months prior to enrollment
- Any other considerations that, in the opinion of the investigators, may adversely affect participant safety, participation, or the scientific validity of the data being collected (e.g., erratic or unreliable responses, inconsistent communication, inability to remain on a steady neurotropic medication and/or behavioral therapy regimen over the course of the Randomization phase of the study.)
- History of severe or recent uncontrolled heart disease
- Presence of a cardiac pacemaker or intracardiac lines
- Presence of rapidly progressive illnesses such as late-stage cancer, neurodegenerative conditions, major organ failure, etc
- History of Bipolar Disorder or Schizophrenia Spectrum Disorders
- Current evidence of substance-induced mood disorder, active psychosis, or depression secondary to general medical illness other than TBI
- Right upper extremity amputation or other condition precluding left motor threshold calibration
- Contraindications to awake 3T MRI without contrast at the time of the Baseline MRI according to site radiology department criteria
- Intracranial lesion that would produce an artifact that would compromise the integrity of rsfMRI data
- Severe or uncontrolled substance use
- Unable to complete timeline of study (e.g., planned hospitalization partway through the study period.)
- Prisoner, or other legally restricted freedom of movement and participation
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
This trial is currently available in United States.
- Alexander T. Augusta Military Medical CenterFort Belvoir, United StatesContact: Vanessa Donahue, BSTaking people
- William Beaumont Army Medical CenterFort Bliss, United StatesContact: Diana HernandezTaking people
- VA Palo Alto Health Care SystemPalo Alto, United StatesContact: Rachel DieterichTaking people
About the trial
What the trial wants to find out
The purpose of this study is to investigate the efficacy, safety, and tolerability of two dorsolateral prefrontal cortex (DLPFC) repetitive transcranial magnetic stimulation (rTMS) protocols to alleviate symptoms of depression in United States (U.S.) military service members and veterans with a history of concussion/mild traumatic brain injury (TBI).
The 3 groups in the trial
- Arm 1Treatment being tested
Active rTMS/Individualized Connectome Targeting (ICT)
Treatment: Repetitive Transcranial Magnetic Stimulation (rTMS)
- Arm 2Treatment being tested
Active rTMS/resting state functional MRI (rsfMRI)-based targeting
Treatment: Repetitive Transcranial Magnetic Stimulation (rTMS)
- Arm 3Sham treatment, for comparison
Sham rTMS
Treatment: Sham rTMS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- ADEPT: Adaptive Trial for the Treatment of Depressive Symptoms Associated With Concussion Using Repetitive Transcranial Magnetic Stimulation Protocols
- Criteria questions
- Built from NCT05426967, who can take part
- Publications
- Record updated
- 29 April 2026